COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Xcovery Holdings is a clinical-stage biopharma developing small-molecule targeted therapeutics for oncology and ophthalmology, including ALK inhibitor X-396 (NSCLC Phase 1/2) and oral VEGF/PDGF inhibitor X-82.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor